{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":22,"n_cols":5,"rows_kept":22,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[12,2,12,3],[13,2,13,3],[18,2,18,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA996201257903316"]
[null,null,"Titolo",null,"Novel and re-emerging respiratory viral diseases [[electronic resource]]"]
[null,null,"Pubbl/distr/stampa",null,"London, : Novartis Foundation, 2008"]
[null,null,"ISBN",null,"1-283-37243-6"]
[{"$nulls":4},"9786613372437"]
[{"$nulls":4},"0-470-77067-8"]
[{"$nulls":4},"0-470-77068-6"]
[null,null,"Descrizione fisica",null,"1 online resource (178 p.)"]
[null,null,"Collana",null,"Novartis Foundation symposium ; ; 290"]
[null,null,"Disciplina",null,"616.2"]
[null,null,"Soggetti",null,"Virus diseases"]
[{"$nulls":4},"Respiratory organs - Diseases"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Symposium on novel and re-emerging respiratory viral diseases, held at the Institute of Molecular and Cell Biology, Singapore, 23-25 April 2007\" --P. v."]
[{"$nulls":4},"\"This meeting was based on a proposal made by Yee-Joo Tand and Wanjin Hong--P. v.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Novel and Re-Emerging Respiratory Viral Diseases; Contents; Chair's introduction; Identification and characterization of novel viruses; DISCUSSION; The evolution of viral emergence; DISCUSSION; Antigenic cartography of human and swine influenza A(H3N2) viruses; DISCUSSION; Influenza pandemics and control; DISCUSSION; On the activation of membrane fusion by influenza haemagglutinin; DISCUSSION; Singapore SARS experience and preparation for future outbreak; DISCUSSION; SARS lessons for a young virology laboratory in Singapore; DISCUSSION"]
[{"$nulls":4},"How the SARS experience has helped preparations for future outbreaks: the Taiwan experience, with emphasis on the successful control of institutional outbreak of influenza in 2003/2004 using a stockpile of antiviralsDISCUSSION; General discussion I; Genetic and antigenic characterization of avian influenza A (H5N1) viruses isolated from humans in mainland China; DISCUSSION; Emerging infectious diseases and the animal-human interface; DISCUSSION; Transmission and pathogenicity of H5N1 influenza viruses; DISCUSSION; Development of vaccine for a future influenza pandemic; DISCUSSION"]
[{"$nulls":4},"FINAL DISCUSSIONContributor Index; Subject Index; Color Plates"]
[null,null,null,"Sommario/riassunto","The past decade has seen mounting global concern regarding viral outbreaks such as SARS, avian influenza and West Nile virus. In 2004 and 2005, reports of bird-to-human, and possible human-to-human, transmissions of the H5N1 influenza viruses raised fears that these viruses could cause a pandemic on the scale of the Spanish flu pandemic of 1918.   Previous to this, a novel coronavirus had been identified as the aetiological agent of the severe acute respiratory syndrome (SARS), a new respiratory viral disease that emerged at the end of 2002 and caused profound disturbances in over 30 countries"]